Abstract:Blood-contacting medical devices (BCMDs) are inevitably challenged by thrombi formation, leading to occlusion of flow and device failure. Ideal BCMDs seek to mimic the intrinsic antithrombotic properties of the human vasculature to locally prevent thrombotic complications, negating the need for systemic anticoagulation. An emerging category of BCMD technology utilizes nitric oxide (NO) as a hemocompatible agent, as the vasculature's endothelial layer naturally releases NO to inhibit platelet activation and consumption. In this paper, we report for the first time the novel impregnation of S-nitrosoglutathione (GSNO) into polymeric poly(vinyl chloride) (PVC) tubing via an optimized solvent-swelling method. Material testing revealed an optimized GSNO-PVC material that had adequate GSNO loading to achieve NO flux values within the physiological endothelial NO flux range for a 4 h period. Through in vitro hemocompatibility testing, the optimized material was deemed nonhemolytic (hemolytic index <2%) and capable of reducing platelet activation, suggesting that the material is suitable for contact with whole blood. Furthermore, an in vivo 4 h extracorporeal circulation (ECC) rabbit thrombogenicity model confirmed the blood biocompatibility of the optimized GSNO-PVC. Platelet count remained near 100% for the novel GSNO-impregnated PVC loops (1 h, 91.08 ± 6.27%; 2 h, 95.68 ± 0.61%; 3 h, 97.56 ± 8.59%; 4 h, 95.11 ± 8.30%). In contrast, unmodified PVC ECC loops occluded shortly after the 2 h time point and viable platelet counts quickly diminished (1 h, 85.67 ± 12.62%; 2 h, 54.46 ± 10.53%; 3 h, n/a; 4 h, n/a). The blood clots for GSNO-PVC loops (190.73 ± 72.46 mg) compared to those of unmodified PVC loops (866.50 ± 197.98 mg) were significantly smaller (p < 0.01). The results presented in this paper recommend further investigation in long-term animal models and suggest that GSNO-PVC has the potential to serve as an alternative to systemic anticoagulation in BCMD applications.

Inhibition of Afterglow Plasma to the Absorption of FIB on PVC

Synthesis of PVC-b-PEG Copolymer and Its Modification Effect on PVC Microfiltration Membrane

Fabrication of Thromboresistant Multilayer Thin Film on Plasma Treated Poly (vinyl Chloride) Surface

Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility

Novel Zinc-polysaccharides Anti-coagulant Coating on Poly (vinyl Chloride) Surface

Hemocompatibility Of Poly(Vinylidene Fluoride) Membrane Grafted With Network-Like And Brush-Like Antifouling Layer Controlled Via Plasma-Induced Surface Pegylation

Hemocompatibility of Poly(acrylonitrile-Co-n-vinyl-2-pyrrolidone)s: Swelling Behavior and Water States.

Self-assembled hemocompatible coating on poly (vinyl chloride) surface

Plasma functionalization of poly(vinyl alcohol) hydrogel for cell adhesion enhancement

Plasma Surface Treatment and Application of Polyvinyl Alcohol/Polylactic Acid Electrospun Fibrous Hemostatic Membrane

Surface Modification of Poly(tetrafluoroethylene) Films Via Plasma Treatment and Graft Copolymerization of Acrylic Acid

Preparation and Biological Evaluations of Heparinized PLLA Films

Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices

Synthesis, characterization and thermal behavior of plasticized poly (vinyl chloride) doped with folic acid-modified titanium dioxide

Investigation of the Impact of Cold Plasma Treatment on the Wettability of Medical Grade Polyvinylchloride

Argatroban- and copper-modified polymers with improved thromboresistance and antimicrobial properties

Comparative Studies on Hydrophilic and Hydrophobic Segments Grafted Poly(vinyl chloride)

Surface Modification of Polypropylene Microfiltration Membranes by the Immobilization of Poly(n-Vinyl-2-pyrrolidone): a Facile Plasma Approach

Improved Polymer Hemocompatibility for Blood-Contacting Applications via S-Nitrosoglutathione Impregnation

Optimization of sulfonated polyethyleneimine zwitterionic coating mediated by polydopamine for poly(vinyl chloride) antifouling

Surface Modification of Silk Fibroin Films with Zwitterionic Phosphobetaine to Improve the Hemocompatibility